表紙:前立腺肥大症 (BPH) の世界市場 (2020年~2027年)
市場調査レポート
商品コード
995488

前立腺肥大症 (BPH) の世界市場 (2020年~2027年)

Global Benign Prostate Hyperplasia (BPH) Market, Size, Share, Opportunities and Forecast, 2020-2027

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.85円
前立腺肥大症 (BPH) の世界市場 (2020年~2027年)
出版日: 2021年04月03日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のBPH(良性前立腺肥大症)市場の主な促進要因として、男性高齢者の人口増加や、前立腺がんや他の泌尿器疾患に対する関心の増大などが挙げられます。他方、新型コロナウイルス感染症 (COVID-19) 感染拡大の余波でBPHの処置を延期する傾向が強まっています。薬剤の種類別ではα遮断薬が、処置別ではTURP (経尿道的前立腺切除) が最大のセグメントとなっています。エンドユーザー別に見ると、在宅治療向け需要のシェアが高くなっています。地域別では北米諸国が最大の市場となる一方、アジア太平洋での急速な市場成長が期待されています。

当レポートでは、世界の前立腺肥大症 (BPH) 向け治療薬の市場について分析し、市場規模の動向見通しや、薬剤の種類別・処置別・エンドユーザー別・地域別の詳細動向、主な市場促進・抑制要因、主要企業のプロファイルなどについて調査しております。

目次

第1章 世界の前立腺肥大症 (BPH) 市場:分析手法・範囲

第2章 世界の前立腺肥大症 (BPH) 市場:市場の定義と概要

第3章 世界の前立腺肥大症 (BPH) 市場:エグゼクティブサマリー

第4章 世界の前立腺肥大症 (BPH) 市場:市場力学

  • 市場への影響要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響力の分析

第5章 世界の前立腺肥大症 (BPH) 市場:産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • バリューチェーン分析
  • PEST分析
  • 価格分析
  • 規制分析
  • 医療費償還の分析
  • アンメットニーズ
  • 特許動向

第6章 世界の前立腺肥大症 (BPH) 市場:新型コロナウイルス感染症 (COVID-19) の分析

  • COVID-19の市場への影響の分析
    • 「ビフォーコロナ」/過去の市場シナリオ
    • 「ウィズコロナ」/現在の市場シナリオ
    • 「アフターコロナ」/将来の市場シナリオ
  • COVID-19流行中の価格動向
  • 需要・供給の変動域
  • 感染拡大時の市場に対する政府の取り組み
  • メーカー各社の戦略展開状況
  • 結論

第7章 世界の前立腺肥大症 (BPH) 市場:薬剤の種類別

  • イントロダクション
    • 市場規模の分析と対前年成長率 (YoY):薬剤の種類別
    • 市場求心力指数:薬剤の種類別
  • α遮断薬
  • 5α-還元酵素阻害剤 (5-ARI)

第8章 世界の前立腺肥大症 (BPH) 市場:処置別

  • イントロダクション
    • 市場規模の分析と対前年成長率 (YoY):処置別
    • 市場求心力指数:処置別
  • 経尿道的前立腺切除 (TURP)
  • 経尿道的マイクロ波療法 (TUMT)
  • 経尿道的ニードルアブレーション (TUNA)
  • その他

第9章 世界の前立腺肥大症 (BPH) 市場:エンドユーザー別

  • イントロダクション
    • 市場規模の分析と対前年成長率 (YoY):エンドユーザー別
    • 市場求心力指数:エンドユーザー別
  • 病院
  • 在宅治療
  • その他

第10章 世界の前立腺肥大症 (BPH) 市場:地域別

  • イントロダクション
    • 市場規模の分析と対前年成長率 (YoY):地域別
    • 市場求心力指数:地域別
  • 北米
    • イントロダクション
    • 域内市場の固有の動向
    • 市場規模の分析と対前年成長率 (YoY):薬剤の種類別
    • 市場規模の分析と対前年成長率 (YoY):処置別
    • 市場規模の分析と対前年成長率 (YoY):エンドユーザー別
    • 市場規模の分析と対前年成長率 (YoY):国別
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ

第11章 世界の前立腺肥大症 (BPH) 市場:競合情勢

  • 競争シナリオ
  • 市場ポジショニング/シェア分析
  • 企業合併・買収 (M&A) の分析

第12章 世界の前立腺肥大症 (BPH) 市場:企業プロファイル

  • Endo International plc
    • 企業概要
    • 製品のポートフォリオ/概略
    • 近年の動向
    • 財務分析:概要
  • KARL STORZ GMBH & CO.KG.
  • Lumenis
  • Olympus Corporation
  • Urologix Inc.
  • Boston Scientific Corporation
  • Coloplast A/S
  • Lisa Laser
  • Medifocus Inc.
  • Neotract Inc.

第13章 世界の前立腺肥大症 (BPH) 市場:重要考察

第14章 DataM Intelligenceについて

目次

Global Benign Prostate Hyperplasia (BPH) Market is segmented By Drug Type (Alpha Blocker, 5-Alpha Reductase Inhibitors), By Surgery (TURP, TUMT, TUNA, Others), By End User (Hospitals, Home Care, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Global Benign Prostate Hyperplasia (BPH) Market is expected to grow at a CAGR of ~ 6% during the forecasting period (2020-2027).

BPH (benign prostatic hyperplasia) is a urological disease marked by the non-cancerous proliferation of prostate gland cells. The gland enlarges as a result of this disease, rubbing against the urethra and limiting urine flow. Aging, hormonal imbalances, and irregular cell growth are also related to this disease. BPH is characterized by excessive urination, trouble starting urine, a poor urinary tract, and the inability to drain the urinary bladder. Men with mild to moderate BPH are currently treated with drugs.

Source: DataM Intelligence Analysis (2019)

Market Dynamics

The growth in the male geriatric population is driving the global benign prostatic hyperplasia therapeutics industry. Other factors driving demand development include increased awareness of prostate cancer and other urological diseases, as well as a rise in the number of patients with benign prostatic hyperplasia around the world.

Rise in Geriatric Population

BPH (benign prostatic hyperplasia) is becoming more commonly recognised as a growing health concern among elderly men. The magnitude of the problem is predicted to multiply in the coming years as the number of elderly men increases. According to a survey released by the United States Census Bureau in 2018, the number of people aged 65 and over in the United States is projected to grow significantly between 2016 and 2060. By 2030, one of every five Americans will be 65 or older, accounting for 78.0 million people out of the current population. By the age of 60, nearly half of men have histopathologic BPH, and by the age of 85, 90% of men have it. BPH signs are said to affect 30 million men globally and 14 million men in the United States.

Side-effects associated with BPH medications

Although both medications and surgery can be used to treat BPH, both have serious side effects. Alpha-blockers, 5-ARIs (5-alpha reductase inhibitors), and other drug groups are widely used to treat BPH. Dizziness, orthostatic hypotension, retrograde ejaculation, and rhinitis are all typical side effects of alpha-blockers. Dizziness and orthostatic hypotension are most frequent in the elderly, and they can lead to severe problems such as falls and fractures. The complications associated with the use of drugs is a key factor expected to curtail growth of the global market over the forecast period.

COVID-19 Impact Analysis

The COVID-19 epidemic is projected to have a major effect on the BPH care industry. Elective surgeries with benign pathology were advised to be deferred until the burden on the medical system from COVID-19 lessened, so hospitals will face a tremendous need for services to tackle a potential rise in COVID-19 incidents. Surgical operations such as TURP, HoLEP, ThuLEP, and PVP had to be delayed as a result.

Benign Prostate Hyperplasia (BPH) Market Segment Analysis

Based on the drug type, the Benign Prostate Hyperplasia (BPH) market has been classified into alpha blocker and 5-alpha reductase inhibitors.

Alpha blocker segment is projected to be the dominated segment in the market during the forecast period.

Alpha blocker dominated the global market in 2019, owing to the strong preference of alpha blocker medications and its used in a wide number of countries. Whereas, the 5-alpha reductase inhibitors is expected to present a considerable growth in the near future.

The global Benign Prostate Hyperplasia (BPH) is segmented on the basis of surgery, which includes TURP, TUMT, TUNA and Others.

TURP is expected to dominate the Benign Prostate Hyperplasia (BPH) market.

TURP held the dominant position in the global market during the forecast period owing to surge in use of TURP surgery globally. Prostate transurethral resection is a urological technique that is used to treat benign prostatic hyperplasia (BPH). It includes visualizing the prostate through the urethra and cutting tissue with electrocautery or sharp dissection. As a result, the demand is expected to increase as TURP becomes more common. Moreover, the TURP is expected to project a considerable CAGR during the forecast period.

Source: DataM Intelligence Analysis (2019)

Benign Prostate Hyperplasia (BPH) is segmented on the basis of end user, which includes hospitals, home care and others.

Home Care is expected to dominate the Benign Prostate Hyperplasia (BPH) market.

Home Care held the dominant position in the global market during the forecast period. The majority of patients are given drugs instead of surgery. Patients are recommended to continue taking their medications for a few weeks after surgery. As a result, the market is driven by home treatment, compared to hospital services. Moreover, the demand is expected to increase with rising preference for home care settings. Therefore, the homecare is expected to project a considerable CAGR during the forecast period.

Benign Prostate Hyperplasia (BPH) Market Geographical Analysis

Based on geography, the study analyzes the Benign Prostate Hyperplasia (BPH) market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is expected to dominate the global Benign Prostate Hyperplasia (BPH) market

North America is held a dominant position in the global Benign Prostate Hyperplasia (BPH) market in 2019. In North America, the U.S. is expected to represent considerable growth during the forecast period. High prevalence of BPH and other associated lower urinary tract symptoms. Several studies over the past decade have shown that a large number of men in the U.S., aged 45 to 80, suffer from lower urinary tract symptoms, with the bulk of them experiencing BPH symptoms, which results in huge market for Benign Prostate Hyperplasia (BPH). Moreover, Europe is expected to represent significant growth in terms of value during the forecast period. Significant investment in R&D and advanced product development is expected to propel the market growth across the region. Benign Prostate Hyperplasia (BPH) market for Asia Pacific is expected to observe rapid growth over the forecast period, backed by the large population base, especially in India and China. Moreover, rise in health care expenditure and rapidly increasing prevalence of various urologic diseases is expected to augment the growth the Asia Pacific Benign Prostate Hyperplasia (BPH) market.

Benign Prostate Hyperplasia (BPH) Market Competitive Landscape

The Benign Prostate Hyperplasia (BPH) market is highly competitive, owing to the presence of big medical companies. The key players which are contributing to the growth of the global market include Endo International plc, KARL STORZ GMBH & CO.KG, Lumenis, Olympus Corporation., Urologix Inc., Boston Scientific Corporation, Coloplast A/S, Lisa Laser, Medifocus Inc, Neotract Inc, among others. The major players are adopting new product launch and expansion strategies for global growth in the Benign Prostate Hyperplasia (BPH) market.  

Holmium Laser Vaporization of the Prostate (Lumenis):

Holmium Laser Vaporization of the Prostate (HoLVP) is a BPH treatment option that is both safe and effective, providing immediate symptom relief with few side effects. Without inducing deeper thermal injury, coagulation necrosis, or collateral damage, the holmium laser penetrates only enough to accurately and rapidly vaporise tissue. HoLVP is a non-invasive, outpatient treatment that provides for a rapid recovery and return to normal life.

Drug Type Portfolio: The Company's portfolio comprises urology treatment solutions such as HoLEP, vaporization among others.

Why Purchase the Report?

Visualize the Benign Prostate Hyperplasia (BPH) market segmentation composition by drug type, surgery, end user and region, highlighting the critical commercial assets and players.

Identify commercial opportunities in the Benign Prostate Hyperplasia (BPH) market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of Benign Prostate Hyperplasia (BPH) market - level 3 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Drug Type mapping in excel for the key products of all major market players

The global Benign Prostate Hyperplasia (BPH) market report would provide access to an approx. 54 market data table, 53 figures and 221 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

Table of Contents

Benign Prostate Hyperplasia (BPH) Market Methodology and Scope

Research Methodology

Research Objective and Scope of the Report

Benign Prostate Hyperplasia (BPH) Market - Market Definition and Overview

Benign Prostate Hyperplasia (BPH) Market - Executive Summary

Market Snippet by Drug Type

Market Snippet by Surgery

Market Snippet by End User

Market Snippet by Region

Benign Prostate Hyperplasia (BPH) Market - Market Dynamics

Market Impacting Factors

Drivers

Rise in Geriatric Population

Increasing awareness of prostate cancer and other urological diseases

Restraints:

Side-effects associated with BPH medications

Impact Analysis

Benign Prostate Hyperplasia (BPH) Market - Industry Analysis

Porter's Five Forces Analysis

Supply Chain Analysis

Value Chain Analysis

PEST Analysis

Pricing Analysis

Regulatory Analysis

Reimbursement Analysis

Unmet Needs

Patent Trends

Benign Prostate Hyperplasia (BPH) Market - COVID-19 Analysis

Analysis of Covid-19 on the Market

Before COVID-19 Market Scenario

Present COVID-19 Market Scenario

After COVID-19 or Future Scenario

Pricing Dynamics Amid Covid-19

Demand-Supply Spectrum

Government Initiatives Related to the Market During Pandemic

Manufacturers Strategic Initiatives

Conclusion 

Benign Prostate Hyperplasia (BPH) Market - By Drug Type

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type Segment

Market Attractiveness Index, By Drug Type Segment

Alpha Blocker*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

5-Alpha Reductase Inhibitors

Benign Prostate Hyperplasia (BPH) Market - By Surgery

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Segment

Market Attractiveness Index, By Surgery Segment

TURP*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

TUMT

TUNA

Others

Benign Prostate Hyperplasia (BPH) Market - By End User

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment

Market Attractiveness Index, By End User Segment

Hospitals*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Home Care

Others

Benign Prostate Hyperplasia (BPH) Market - By Region

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

Market Attractiveness Index, By Region

North America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

U.S.

Canada

Mexico

Europe

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Germany

U.K.

France

Italy

Spain

Rest of Europe

South America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User 

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Brazil

Argentina

Rest of South America

Asia Pacific

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

China

India

Japan

Australia

Rest of Asia Pacific

Middle East and Africa

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Benign Prostate Hyperplasia (BPH) Market - Competitive Landscape

Competitive Scenario

Market Positioning/Share Analysis

Mergers and Acquisitions Analysis

Benign Prostate Hyperplasia (BPH) Market- Company Profiles

Endo International plc*

Company Overview

Drug Type Portfolio and Description

Key Highlights

Financial Overview

KARL STORZ GMBH & CO.KG.

Lumenis

Olympus Corporation

Urologix Inc.

Boston Scientific Corporation

Coloplast A/S

Lisa Laser

Medifocus Inc.

Neotract Inc. (LIST NOT EXHAUSTIVE)

Benign Prostate Hyperplasia (BPH) Market - Premium Insights

Benign Prostate Hyperplasia (BPH) Market - MSG Analysis

Appendix

About Us and Services

Contact Us

Suggestions for Related Market Report:

Prostate Cancer Market

Continence Care market

Intermittent Catheters Market

Catheters Market